1. Home
  2. BOLD vs ZEPP Comparison

BOLD vs ZEPP Comparison

Compare BOLD & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • ZEPP
  • Stock Information
  • Founded
  • BOLD 2018
  • ZEPP 2013
  • Country
  • BOLD United States
  • ZEPP China
  • Employees
  • BOLD N/A
  • ZEPP N/A
  • Industry
  • BOLD
  • ZEPP Computer Manufacturing
  • Sector
  • BOLD
  • ZEPP Technology
  • Exchange
  • BOLD Nasdaq
  • ZEPP Nasdaq
  • Market Cap
  • BOLD 49.5M
  • ZEPP 44.0M
  • IPO Year
  • BOLD 2024
  • ZEPP N/A
  • Fundamental
  • Price
  • BOLD $1.51
  • ZEPP $2.96
  • Analyst Decision
  • BOLD Buy
  • ZEPP
  • Analyst Count
  • BOLD 3
  • ZEPP 0
  • Target Price
  • BOLD $22.50
  • ZEPP N/A
  • AVG Volume (30 Days)
  • BOLD 82.4K
  • ZEPP 28.6K
  • Earning Date
  • BOLD 03-27-2025
  • ZEPP 03-26-2025
  • Dividend Yield
  • BOLD N/A
  • ZEPP N/A
  • EPS Growth
  • BOLD N/A
  • ZEPP N/A
  • EPS
  • BOLD N/A
  • ZEPP N/A
  • Revenue
  • BOLD N/A
  • ZEPP $182,603,000.00
  • Revenue This Year
  • BOLD N/A
  • ZEPP N/A
  • Revenue Next Year
  • BOLD N/A
  • ZEPP $18.94
  • P/E Ratio
  • BOLD N/A
  • ZEPP N/A
  • Revenue Growth
  • BOLD N/A
  • ZEPP N/A
  • 52 Week Low
  • BOLD $1.42
  • ZEPP $2.06
  • 52 Week High
  • BOLD $14.72
  • ZEPP $4.38
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • ZEPP 46.09
  • Support Level
  • BOLD N/A
  • ZEPP $3.30
  • Resistance Level
  • BOLD N/A
  • ZEPP $3.51
  • Average True Range (ATR)
  • BOLD 0.00
  • ZEPP 0.28
  • MACD
  • BOLD 0.00
  • ZEPP -0.03
  • Stochastic Oscillator
  • BOLD 0.00
  • ZEPP 17.62

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About ZEPP Zepp Health Corporation

Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.

Share on Social Networks: